Highly selective CB1cannabinoid receptor ligands and novel CB1/VR1vanilloid receptor ୀhybridୁ ligands

Biochemical and Biophysical Research Communications

Volumn 281, Issue 2, 2001, Pages 444-451

  Di Marzo, V ^a   Bisogno, T ^a   De Petrocellis, L ^a   Brandi, I ^a   Jefferson, R G ^b   Winckler, R L ^b   Davis, J B ^c   Dasse, O ^d   Mahadevan, A ^d   Razdan, R K ^d   Martin, B R ^b  

^a CNR   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d ORGANIX INC   (United States)

Author keywords

2 arachidonoylglycerol; Analgesia; Anandamide; Arvanil; Cannabinoid; Capsaicin; Endocannabinoid; Receptor; Vanilloid

Indexed keywords

1' METHYL 2' HYDROXYETHYLARACHIDONAMIDE; 1',1' DIMETHYLHEPTYL N (3 METHOXY 4 HYDROXYBENZYL)ARACHIDONAMIDE; 1,1' DIMETHYLPENTYL 1' METHYL 2' HYDROXYETHYLARACHIDONAMIDE; 1,1' DIMETHYLPENTYL N (3 METHOXY 4 HYDROXYBENZYL)ARACHIDONAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; IONOMYCIN; LIGAND; N (3 METHOXY 4 HYDROXYBENZYL)ARACHIDONAMIDE; O 1811; O 1812; O 1839; O 1856; O 1860; O 1861; O 1895; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; MALE; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0034808060     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4354     Document Type: Article

References (26)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. Pharmacology of cannabinoid CB1 and CB2 receptors
3. Endocannabinoids
4. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
5. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
6. The capsaicin receptor: A heat-activated ion channel in the pain pathway
7. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
8. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes
9. Levels, metabolism and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice. Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain
10. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
11. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
12. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): Vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors
13. Neurobehavioral activity in mice of N-vanillyl-arachidonylamide
14. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
15. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
16. (R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability
17. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries
18. Potent anandamide analogs: The effect of changing the length and branching of the end pentyl chain
19. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1
20. The synthesis of N-vanillyl-arachidonoyl-amide (arvanil) and its analogues: An improved procedure for the synthesis of the key synthon methyl-14-hydroxy-(all-cis)-5, 8, 11-tetradecatrienoate
21. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
22. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion
23. Vasodilator activity of arvanil (N-arachidonoyl-vanillyl-amide), a novel "hybrid" activator of vanilloid and cannabinoid receptors
24. New perspectives on enigmatic vanilloid receptors
25. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells
26. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase